AbZ-Pharma GmbH secures contract for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Enalapril (without 2.5 mg 5 mg), ATC C09AA02 for the period 010526 - 300428 (plus V option 1x12 months)

Posted On: 2026-10-02

Germany, Oct. 2 -- Germany based AbZ-Pharma GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Enalapril (without 2.5 mg 5 mg), ATC C09AA02 for the period 010526 - 300428 (plus V option 1x12 months) . The value of the contract is not disclosed .

Published by HT Digital Content Services with permission from Pivotal Sources....

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

AbZ-Pharma GmbH secures contract for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Enalapril (without 2.5 mg 5 mg), ATC C09AA02 for the period 010526 - 300428 (plus V option 1x12 months)